Bilirubin: An Endogenous Inducer of Nrf2 Pathway and Its Possible Application in Therapy- Juniper Publishers
JUNIPER PUBLISHERS-OPEN ACCESS JOURNAL OF TOXICOLOGY
Bilirubin: An Endogenous Inducer of Nrf2 Pathway and Its Possible Application in Therapy
Authored by Mohammed Qaisiya
Abstract
It has been asked, why convert-in a step that consumes
energy-biliverdin a non-toxic easily excretable waste product, into bilirubin,
that is excretable, neurotoxic, and must be further metabolized for dispose?
This two page opinion focus on the possible effects of bilirubin on an
important cyto-protective pathway named Nrf2 antioxidant signaling. In animals,
the product of oxidative degradation of heme results in a yellow pigment named
un-conjugated bilirubin [UCB] that has a significant importance role during
physiological and pathological conditions. UCB once produced is transferred
into liver and then conjugated with glucuronic acid by the enzyme UGT1A1. UCB
is responsible for neonatal jaundice that occurs in most newborn during the
first week of life. However, UCB is a potential neurotoxic and in very few
cases, such as Crigler Najjar syndrome type I in which the activity of UGT1A1
is completely absent; UCB leads to neurotoxicity or kernicterus. UCB plays a
major role as a significant antioxidant at physiological levels, although we
are still far from a complete understanding of this phenomenon. The antioxidant
ability of UCB arises from a popular explanation of redox consuming cycling
mechanism that act between the conversions of UCB in biliverdin. Several in
vitro studies support the "direct" antioxidant properties of UCB.
For more Open Access Journals in Juniper Publishers please
click on: https://juniperpublishers.com
For more articles in Open Access Journal of Toxicology please
click on: https://juniperpublishers.com/oajt/
To know more about Peer Review Journal of Toxicology
To read more… Full text please click on: https://juniperpublishers.com/oajt/OAJT.MS.ID.555561.php
Comments
Post a Comment